MannKind | Profitto Lordo Sulle Vendite



Gross Profit On Sales Cambiamento Data
Adma Biologics USD 63.33M 3.67M 2024-12
Dynavax Technologies USD 58.62M 8.92M 2024-12
Eli Lilly USD 10.5B 624.7M 2025-03
Halozyme Therapeutics USD 255.95M 15.3M 2024-12
Insmed USD 78.29M 6.04M 2024-12
MacroGenics USD 13.86M 94.98M 2024-12
MannKind USD 59.17M 6.82M 2024-12
Merck USD 12.77B 849M 2025-03
Novo Nordisk DKK 60B 2.22B 2024-09
Pfizer USD 11.12B 987M 2025-03
Sanofi EUR 7.72B 2.36B 2025-03
Xencor -45143000 40.69M 2024-09



MannKind Profitto Lordo Sulle Vendite - Valori correnti, dati storici, previsioni, statistiche, grafici e calendario economico - May 2025.